drugset / Trial / NCT02844309
The Efficacy of TCD Following by TP Maintenance Therapy in Newly Diagnosed WM
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to evaluate the efficiency of an oral regimen in newly diagnosed Waldenström macroglobulinemia: thalidomide plus cyclophosphamide and dexamethasone following by thalidomide and prednisone maintenance therapy.
Timeline
- Start
- 2016-05
- Primary completion
- 2019-11
- Completion
- 2020-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Thalidomide | Other / unclassified | 50 mg | — |
| Subject | Thalidomide | Other / unclassified | 150 mg | — |